ArticleJournal of hematology2023

Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.

Clinton Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.